Hamburg Plans To Step Down In March, Views Science-Based Regulation As Her Legacy

FDA Commissioner Margaret Hamburg informed her staff Thursday that she will step down the end of March, with agency Chief Scientist Stephen Ostroff slated to take over as acting commissioner just as the new GOP Congress takes up major FDA reforms, the first biosimilar decision is on tap and the White House pushes a new Precision Medicine Initiative. But Hamburg leaves her own legacy after nearly six years as FDA chief, ticking off major efforts spanning from food safety to...